Moreover, the inactivation of ILK suppresses Yes-associated protein (YAP) activation and tumor growth in vivo [20], indicating that ILK plays a critical role in the suppression of the Hippo pathway in BC cells. This evidence concerns the gene ILK and breast cancer.